A clinical trial to examine disparities in quitting between African-American and White adult smokers: Design, accrual, and baseline characteristics.

ABSTRACT:

Background

African-Americans smoke fewer cigarettes per day than Whites but experience greater smoking attributable morbidity and mortality. African-American-White differences may also exist in cessation but rigorously designed studies have not been conducted to empirically answer this question.

Methods/design

Quit2Live is, to our knowledge, the first head-to-head trial designed with the primary aim of examining African-American-White disparities in quitting smoking. Secondary aims are to identify mechanisms that mediate and/or moderate the relationship between race and quitting. The study is ongoing. Study aims are accomplished through a 5-year prospective cohort intervention study designed to recruit equal numbers of African-Americans (n=224) and Whites (n=224) stratified

SUBMITTER: Nollen NL 

PROVIDER: S-EPMC4818177 | biostudies-literature | 2016 Mar

REPOSITORIES: biostudies-literature